UBS Group’s Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 NUVB.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27 | Sell |
99
-2,507
| -96% | -$684 | ﹤0.01% | 8773 |
|
|
2025
Q1 | $516 | Buy |
2,606
+2,571
| +7,346% | +$509 | ﹤0.01% | 8431 |
|
|
2024
Q4 | $8 | Buy |
+35
| New | +$8 | ﹤0.01% | 8571 |
|
|
2024
Q2 | – | Sell |
-100
| Closed | -$30 | – | 8641 |
|
|
2024
Q1 | $30 | Buy |
+100
| New | +$30 | ﹤0.01% | 7817 |
|
|
2023
Q4 | – | Sell |
-84
| Closed | -$8 | – | 8418 |
|
|
2023
Q3 | $8 | Buy |
+84
| New | +$8 | ﹤0.01% | 8093 |
|
|
2023
Q1 | – | Sell |
-505
| Closed | -$71 | – | 8844 |
|
|
2022
Q4 | $71 | Sell |
505
-1,660
| -77% | -$233 | ﹤0.01% | 9241 |
|
|
2022
Q3 | $0 | Hold |
2,165
| – | – | ﹤0.01% | 9530 |
|
|
2022
Q2 | $1K | Buy |
2,165
+208
| +11% | +$96 | ﹤0.01% | 8876 |
|
|
2022
Q1 | $1K | Sell |
1,957
-34
| -2% | -$17 | ﹤0.01% | 8832 |
|
|
2021
Q4 | $4K | Sell |
1,991
-9
| -0.5% | -$18 | ﹤0.01% | 8410 |
|
|
2021
Q3 | $5K | Sell |
2,000
-1,801
| -47% | -$4.5K | ﹤0.01% | 7396 |
|
|
2021
Q2 | $10K | Sell |
3,801
-5,053
| -57% | -$13.3K | ﹤0.01% | 6952 |
|
|
2021
Q1 | $24K | Buy |
+8,854
| New | +$24K | ﹤0.01% | 6189 |
|